Isis and Biogen Idec
have been nominated this year for the Thomson Reuters 2013 Breakthrough Alliance Deal of the Year
for their Broad Neurological Disease Alliance.
Please vote for us!

Vote Here

Current Advances

Isis Scientists Demonstrate Significant Potency of Generation 2.5 Antisense Drugs in Multiple Tissues

Learn More